Today we are thrilled to introduce Mary (Ellie) Dillon who recently joined our team in Stockholm as Lead Analyst!
Ellie is currently finishing her PhD at Aalto University Business School, Finland, […]
Quantify’s Alexander Rieem Dun and Jonas Banefelt are co-authors on a recent publication on the effects of intensity and adherence to lipid-lowering treatment on the risk of cardiovascular events in patients with […]
We are excited to introduce our new Director Dr. Béranger Lueza who joined our international Modelling, Access and Strategy unit this week. Béranger is based in Stockholm and has more […]
Earlier this week the U.S. Food and Drug Administration (FDA) granted accelerated approval to Vijoice® (alpelisib) based primarily on real-world evidence (RWE). The decision reflects the increasing importance of real-world data (RWD) […]
Today we are delighted to introduce Ethan O’Leary who joined our Stockholm team as a Research Analyst this Monday!
Ethan is currently finishing his Master’s in Economics from Stockholm School […]
Quantify’s Christoph Abé (PhD) publishes the largest-ever study associating bipolar disorder with abnormal brain changes over time in the renowned journal Biological Psychiatry, using neuroimaging data.
—
Our Lead Analyst, Christoph Abé (PhD) led an international […]
Check out this recent publication from Quantify, presenting a new conceptual framework in psoriasis that differentiates psoriasis severity from disease control (Link to article: https://onlinelibrary.wiley.com/doi/10.1111/bjd.21023https://lnkd.in/gJtZtENB). Authored by Quantify’s CEO Kirk Geale, […]
At Quantify, we work a lot with ICD codes. And we mean a lot! So much, in fact, that we have discovered some pretty obscure codes that you might not be aware […]